Pattern and predictors of dyslipidemia in patients with type 2 diabetes mellitus

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 7, Issue 2, 2013, Pages 95-100

  Karim, Md N ^a   Ahmed, Kazi R ^b   Bukht, Mohammad S ^c   Akter, Jesmin ^b   Chowdhury, Hasina A ^b   Hossain, Sharmin ^b   Anwar, Nazneen ^d   Selim, Shajada ^e   Chowdhury, Shahabul H ^f   Hossain, Fawzia ^f   Ali, Liaquat ^b  

^a Directorate General of Health Services   (Bangladesh)

^b Bangladesh Institute of Health Sciences (BIHS)   (Bangladesh)

^c RESEARCH AND EVALUATION DIVISION   (Bangladesh)

^d Research Division of Directorate General of Health Services   (Bangladesh)

^e BIRDEM   (Bangladesh)

^f BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

Author keywords

Cardio vascular disease; Dyslipidemia; T2DM; TC HDL ratio and LDL HDL ratio

Indexed keywords

CREATININE; HEMOGLOBIN A1C; TRIACYLGLYCEROL;

ARTICLE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; DYSLIPIDEMIA; FEMALE; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 84877766956     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2013.02.011     Document Type: Article

References (49)

1. A.D. Mooradian Cardiovascular disease in type 2 diabetes mellitus: current management guidelines Archives of Internal Medicine 163 2003 33 40
2. S.V. Koskinen, A.R. Reunanen, T.P. Martelin, and T. Valkonen Mortality in a large population-based cohort of patients with drug-treated diabetes mellitus American Journal of Public Health 88 May (5) 1998 765 770
3. B. Lamarche, A. Tchernof, S. Moorjani, B. Cantin, G.R. Dagenais, and P.J. Lupien Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study Circulation 95 1997 69 75
4. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease. The Framingham study JAMA 241 19 1979 2035 2038
5. D.M. Thompson Cardiovascular disease and diabetes BC Endocrine Research Foundation Newsletter 1 1999 3
6. J.A. Colwell, and R.W. Nesto The platelet in diabetes: focus on prevention of ischemic events Diabetes Care 26 7 2003 2181 2188
7. J. Stamler Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
8. J.M. Sprafka Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey Diabetes Care 14 1991 537 543
9. S.M. Haffner Dyslipidemia management in adults with diabetes Diabetes Care 27 January (Suppl. 1) 2004 S68 S71
10. W.V. Brown Risk factors for vascular disease in patients with diabetes Diabetes, Obesity & Metabolism 2 November (Suppl. 2) 2000 S11 S18
11. P.V. Halushka, R.C. Rogers, C.B. Loadholt, and J.A. Colwell Increased platelet thromboxane synthesis in diabetes mellitus Journal of Laboratory and Clinical Medicine 97 January (1) 1981 87 96
12. American Diabetes Association Management of dyslipidemia in adults with diabetes (position statement) Diabetes Care 26 Suppl. 1 2003 S83 S86
13. M.A. Austin, M.C. King, K.M. Vranizan, and R.M. Krauss Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk Circulation 82 1990 495 506
14. World Health Organization Definition, Diagnosis and Classification of Diabetes Mellitus and its Complication. Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus 1999 World Health Organization, Department of Noncommunicable Disease Surveillance Geneva
15. World Health Organization. Obesity and overweight. World Health Report; 2002.
16. G.K. Dowse, A.R.G. Humphrey, V.R. Collins, W. Plehwe, H. Gareeboo, and D. Fareed Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius American Journal of Epidemiology 147 1998 448 457
17. American Diabetes Association. Clinical practice recommendation. American Diabetes Association (ADA); 2009.
18. American Diabetes Association (ADA) Standards of medical care in diabetes Diabetes Care 30 2007 4 41
19. E. Barrett-Connor, S.M. Grundy, and M.J. Holdbrook Plasma lipids and diabetes mellitus in an adult community American Journal of Epidemiology 115 1982 657 663
20. B. Seyoum, J. Abdulkadir, P. Berhanu, Y. Feleke, Z. Mengistu, and Y. Worku Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients Ethiopian Medical Journal 41 1 2003 1 8
21. J.M. Lawrence, P. Bennett, A. Young, and A.M. Robinson Primary care screening for diabetes in general practice: cross sectional population study BMJ 323 2001 548 551
22. W.B. Kannel Lipids, diabetes, and coronary heart disease: insights from the Framingham Study American Heart Journal 110 1985 1100 1107
23. [No authors listed] UKPDS U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex Diabetes Care 20 1997 1683 1687
24. A. Joshua, B. Becham, and P. Libby Diabetes and atherosclerosis JAMA 287 2002 2570 2581
25. S.M. Haffner, S. Lehto, T. Rönnemaa, K. Pyörälä, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior history of myocardial infarction The New England Journal of Medicine 339 1998 229 234
26. R.P. Dullaart Type 2 diabetes mellitus is associated with differential effects on plasma cholesteryl ester transfer protein and phospholipid transfer protein activities and concentrations Scandinavian Journal of Clinical and Laboratory Investigation 64 2004 205 215
27. S.E. Borggreve Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins European Journal of Clinical Investigation 33 2003 1051 1069
28. M. Bluher, J. Kratzsch, and R. Paschke Plasmalevels of tumor necrosis factor, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance Diabetes Care 24 2001 328 334
29. A. Dresner, D. Laurent, M. Marcucci, M.E. Griffin, S. Dufour, and G.W. Cline Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity The Journal of Clinical Investigation 103 1999 253 259
30. G.M. Reaven, and Y.D. Chen Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus The American Journal of Medicine 85 1988 106 112
31. T. Almdal, H. Scharling, J.S. Jensen, and H. Vestergaard The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up Archives of Internal Medicine 164 2004 1422 1426
32. S.B. Hachem, and A.D. Mooradian Familial dyslipidaemias: an overview of genetics, pathophysiology and management Drugs 66 2006 1949 1969
33. (ADA). American Diabetes Association Management of dyslipidemia in adults with diabetes Diabetes Care 25 suppl 1 2002 Jan S74 S77
34. W.T. Garvey, S. Kwon, D. Zheng, S. Shaughnessy, P. Wallace, and A. Hutto Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance Diabetes 52 2003 453 462
35. A.D. Mooradian Dsylipidemia in type 2 diabetes mellitus Nature Clinical Practice Endocrinology and Metabolism 5 2008 3150 3159
36. E. Barrett-Connor, E.G. Giardian, A.K. Gitt, U. Gudat, H.O. Steinberg, and D. Tscheope Women and heart disease: the role of diabetes and hyperglycemia Archives of Internal Medicine 164 9 2004 9344 9942
37. M. Vergeer Evaluation of phospholipid transfer protein as a therapeutic target Future Lipidology 3 2008 327 335
38. W.Y. Craig, L.M. Neveux, G.E. Palomaki, M.M. Cleveland, and J.E. Hadow Lipoprotein (a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies Clinical Chemistry 44 11 1998 2301 2306
39. A. Juutilainen, S. Kortelainen, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Gender difference in the impact of type 2 diabetes on coronary heart disease risk Diabetes Care 27 December (12) 2004 2898 2904
40. A.M. Kanaya, D. Grady, and E. Barrett-Connor Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta analysis Archives of Internal Medicine 162 August (15) 2002 1737 1745
41. B.V. Howard, L.D. Cowan, O. Go, T.K. Welty, D.C. Robbins, and E.T. Lee Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study Diabetes Care 21 August (8) 1998 1258 1265
42. R.D. Siegel, A. Cupples, E.J. Schaefer, and P.W. Wilson Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study Metabolism: Clinical and Experimental 45 October (10) 1996 1267 1272
43. J.B. Saaddine, M.M. Engelgau, G.L. Beckles, E.W. Gregg, T.J. Thompson, and K.M. Narayan A diabetes report card for the United States: quality of care in the 1990s Annals of Internal Medicine 136 2002 565 574
44. N.M. Abdel-Aal, A.T. Ahmet, E.S. Froelicher, A.M.S. Batieha, M.M. Hamza, and K.M. Ajloni Prevalance of dyslipidemia in patients with type 2 diabetes mellitus in Jordan Saudi Medical Journal 29 10 2008 1423 1428
45. B. Gonen, N. White, and G. Schonfeld Plasma levels of appoprotein B in patients with diabetes mellitus; the effect of glycimec control Metabolism 34 1985 675 679
46. C.J. Schwart, A.J. Valente, E.A. Spargue, J.L. Kelly, A.J. Cayatte, and M. Rozels Pathogenesis of the atherosclerotic lesion: implication for diabetes mellitus Diabetes Care 15 1992 1156 1167
47. N. Talat, K. Amir, M. Gulsena, and B. Bilal Dyslipidemias in type 2 diabetes mellitus patients in a teaching hospital of Lahore, Pakistan Pakistan Journal of Medical Sciences 19 2003 283 286
48. S.B. Harris, J.M. Ekoé, Y. Zdanowicz, and S. Webster-Bogaert Glycemic control and morbidity in the Canadian primary care setting (results of the diabetes in Canada evaluation study) Diabetes Research and Clinical Practice 70 2005 90 97
49. H.O. Otamere, C.P. Aloamaka, P.O. Okokhere, and W.A. Adisa Lipid profile in diabetes mellitus; What impact has age and duration British Journal of Pharmacology and Toxicology 2 3 2011 135 137